Dobutamine Hydrochloride Injection Shortage
Last Updated: September 15, 2025
Status: Current
Unavailable, Current:
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (Hospira, Inc., a Pfizer Company)
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (Hospira, Inc., a Pfizer Company)
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (Hospira, Inc., a Pfizer Company)
- Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (Hospira, Inc., a Pfizer Company)
Available, Current:
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (Baxter Healthcare)
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (Baxter Healthcare)
- Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (Baxter Healthcare)
- Dobutamine Hydrochloride, Injection, 250 mg/20 mL (Hainan Poly Pharm. Co., Ltd.)
- Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (Hospira, Inc., a Pfizer Company)
To Be Discontinued:
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (400 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-3724-32Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Next Delivery: November 2025; Estimated Recovery: December 2025
Therapeutic category: Cardiovascular; Pediatric; Renal
Change date: December 19, 2024
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (100 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-2346-32Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Next Delivery: November 2025; Estimated Recovery: December 2025
Therapeutic category: Cardiovascular; Pediatric; Renal
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (200 mg/mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-2347-32Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Next Delivery: November 2025; Estimated Recovery: December 2025
Therapeutic category: Cardiovascular; Pediatric; Renal
Change date: December 19, 2024
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-2344-88Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Shortage per Manufacturer: Manufacturing Delay
Therapeutic category: Cardiovascular; Pediatric; Renal
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1073-02Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular; Pediatric; Renal
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1075-02Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular; Pediatric; Renal
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (Baxter Healthcare)
NDC Code: 0338-1077-02Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Cardiovascular; Pediatric; Renal
Initial posting date: November 6, 2017
Contact info: 888-229-0001
Dobutamine Hydrochloride, Injection, 250 mg/20 mL (Hainan Poly Pharm. Co., Ltd.)
NDC Code: 70436-203-80Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Related Information: Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988
Therapeutic category: Cardiovascular; Pediatric; Renal
Initial posting date: November 6, 2017
Contact info: Slate Run Pharmaceuticals, LLC: 844-529-8988
Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-2344-01Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Revised
Therapeutic category: Cardiovascular; Pediatric; Renal
Change date: December 19, 2024
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (Hospira, Inc., a Pfizer Company)
NDC Code: 0409-2344-02Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Revised
Therapeutic category: Cardiovascular; Pediatric; Renal
Change date: December 19, 2024
Initial posting date: November 6, 2017
Contact info: 844-646-4398
Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (Pfizer Inc.)
NDC Code: 0409-2344-88Status: To Be Discontinued
Date of update: August 27, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Cardiovascular; Pediatric; Renal
Date discontinued: August 27, 2025
Initial posting date: August 27, 2025
Contact info: 844-646-4398
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.